News & Blogs

Werfen acquires Omixon

Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for […]

Automated C3d DAT Assay Now Available!

Streamline your workflow with Immucor’s new Automated C3d DAT Assay, available on the Echo Lumena®/Echo® (v2.0) and NEO Iris®/NEO® (v2.0). Immucor’s automated instruments allow you to set up a testing profile to perform the IgG DAT and C3d DAT at […]

NEW and Definitely Improved!

You deserve exceptional service/support and our NEW Customer Center is a testament to our commitment to your satisfaction. This innovative platform serves as a hub where you can access a wide range of resources, tools, and services to enhance your […]

Werfen Completes Acquisition of Immucor, Inc.

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and […]

Corporate Social Responsibility

Immucor is dedicated to supporting our global and local communities and environments through the giving of our time, talents and money in order to transform a life. With sites located throughout the world, Immucor provides the support needed for all […]